Related Experiment Video
Updated: Aug 9, 2026
12:31
In Vivo Modeling of the Morbid Human Genome using Danio rerio
Published on: August 24, 2013
The global problem of genetic disease
1Weatherall Institute of Molecular Medicine, University of Oxford, UK. liz.rose@imm.ox.ac.uk
Annals of Human Biology
|August 13, 2005
Summary
Inherited hemoglobin disorders pose a growing global health challenge. Implementing established screening methods and understanding environmental impacts are crucial for effective management and prevention programs.
Area of Science:
- Genetics and Molecular Biology
- Public Health
- Clinical Medicine
Background:
- Inherited hemoglobin disorders represent a significant and escalating health burden, particularly in developing nations.
- While molecular pathology is understood, the environmental factors influencing disease presentation require further investigation.
- Existing screening methods are cost-effective and essential for assessing the future scope of these conditions.
Purpose of the Study:
- To highlight the increasing health burden of inherited hemoglobin disorders globally.
- To emphasize the need for further research into environmental influences on disease course.
- To advocate for the application of established screening and counseling programs, especially in regions lacking prenatal diagnostic expertise.
Main Methods:
- Review of existing knowledge on molecular pathology and phenotypic diversity.
- Discussion of established and inexpensive screening methodologies.
- Emphasis on the potential of environmental factor research for improved clinical management.
Main Results:
- Inherited hemoglobin disorders are a growing public health concern with significant implications for developing countries.
- Environmental factors play a critical, yet often unquantified, role in modifying the clinical presentation of these disorders.
- Established screening and counseling programs are vital for disease control and prevention.
Conclusions:
- Urgent implementation of screening programs is necessary to define the future magnitude of inherited hemoglobin disorders.
- Further research into environmental influences can significantly improve patient management.
- Development of regional networks, particularly in Asia, is recommended for applying established technologies to control and prevent these disorders.
Related Concept Videos
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
00:49What is Genetic Engineering?
Overview
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:31Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...